Evaluation of Enzyme Inhibitors in Drug Discovery

Discover the essential insights into drug discovery with the second edition of Evaluation of Enzyme Inhibitors in Drug Discovery by Robert A. Copeland. Published by John Wiley & Sons Inc in 2013, this comprehensive hardback spans 576 pages, providing an in-depth analysis of enzyme interactions and their crucial role as drug targets. Understanding how enzymes interact with inhibitors is vital for advancing your knowledge in the field of pharmacology and enhancing drug development strategies. This book is an invaluable resource for researchers, students, and professionals alike, offering a detailed exploration of the methodologies and applications in enzyme inhibition. Elevate your expertise in drug discovery with this must-have addition to your library.